Skip to main content
Top
Published in: Clinical Rheumatology 1/2017

01-01-2017 | Original Article

Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis

Authors: Vahid Ziaee, Marzieh Maddah, Mohammad-Hassan Moradinejad, Arezou Rezaei, Samaneh Zoghi, Maryam Sadr, Sara Harsini, Nima Rezaei

Published in: Clinical Rheumatology | Issue 1/2017

Login to get access

Abstract

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children. Genetics and inflammatory elements seem to act as major underlying factors in its pathogenesis. The aim of this study is to identify the associations between interleukin-6 (IL-6) gene polymorphisms and individuals’ vulnerability to JIA in a group of Iranian pediatric patients. Fifty-four patients with JIA were enrolled in this investigation and compared with 139 healthy individuals. Using polymerase chain reaction with sequence-specific primers, cytokine genotyping was performed. The allele and genotype frequencies of two single nucleotide polymorphisms (SNPs) within the IL-6 gene at −174 and +565 positions were assessed. A significant positive association was observed for IL -6 −174 G allele in the patient group (p = 0.02). Furthermore, a positive association was observed in patients with JIA for the GG genotype at the same position (p < 0.01), thus revealing a predisposing effect in JIA patients. On the other hand, a significant negative association was found for IL-6 −174 CG genotype (p < 0.01) in the case group. No significant difference was discovered in both the allelic and genotypic frequencies of IL-6 +565 position between patients and controls. Additionally, haplotype analysis divulged over representation of IL-6 GG haplotype in patient group (p < 0.01) as well as IL-6 CG haplotype in healthy controls (p < 0.01). Certain allele, genotype, and haplotype in IL-6 gene were over expressed in patients with JIA, which probably could render individuals more susceptible to this disease.
Literature
1.
2.
go back to reference Oen K (2000) Comparative epidemiology of the rheumatic diseases in children. Curr Opin Rheumatol 12:410–414CrossRefPubMed Oen K (2000) Comparative epidemiology of the rheumatic diseases in children. Curr Opin Rheumatol 12:410–414CrossRefPubMed
3.
go back to reference Berkun Y, Padeh S (2010) Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 9:A319–A324CrossRefPubMed Berkun Y, Padeh S (2010) Environmental factors and the geoepidemiology of juvenile idiopathic arthritis. Autoimmun Rev 9:A319–A324CrossRefPubMed
4.
go back to reference Singh S, Bhattad S, Danda D (2014) Genetics of juvenile idiopathic arthritis. Int J Rheum Dis 17:233–236CrossRefPubMed Singh S, Bhattad S, Danda D (2014) Genetics of juvenile idiopathic arthritis. Int J Rheum Dis 17:233–236CrossRefPubMed
5.
go back to reference Dimopoulou DG, Zervou MI, Trachana M, et al. (2013) Investigation of juvenile idiopathic arthritis susceptibility loci: results from a Greek population. Hum Immunol 74:1194–1198CrossRefPubMed Dimopoulou DG, Zervou MI, Trachana M, et al. (2013) Investigation of juvenile idiopathic arthritis susceptibility loci: results from a Greek population. Hum Immunol 74:1194–1198CrossRefPubMed
6.
go back to reference Hollegaard MV, Bidwell JL (2006) Cytokine gene polymorphism in human disease: on-line databases, supplement 3. Genes Immun 7:269–276CrossRefPubMed Hollegaard MV, Bidwell JL (2006) Cytokine gene polymorphism in human disease: on-line databases, supplement 3. Genes Immun 7:269–276CrossRefPubMed
7.
go back to reference Tahghighi F, Ziaee V, Moradinejad MH, et al. (2015) Tumor necrosis factor-alpha single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Hum Immunol 76:533–536CrossRefPubMed Tahghighi F, Ziaee V, Moradinejad MH, et al. (2015) Tumor necrosis factor-alpha single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Hum Immunol 76:533–536CrossRefPubMed
8.
go back to reference Mahmoudi M, Tahghighi F, Ziaee V, et al. (2014) Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet 41:512–517CrossRefPubMed Mahmoudi M, Tahghighi F, Ziaee V, et al. (2014) Interleukin-4 single nucleotide polymorphisms in juvenile systemic lupus erythematosus. Int J Immunogenet 41:512–517CrossRefPubMed
9.
go back to reference Rezaei A, Ziaee V, Sharabian FT, et al. (2015) Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. Clin Rheumatol 34:1059–1064CrossRefPubMed Rezaei A, Ziaee V, Sharabian FT, et al. (2015) Lack of association between interleukin-10, transforming growth factor-beta gene polymorphisms and juvenile-onset systemic lupus erythematosus. Clin Rheumatol 34:1059–1064CrossRefPubMed
10.
go back to reference Ziaee V, Tahghighi F, Moradinejad MH, et al. (2014) Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 25:35–40PubMed Ziaee V, Tahghighi F, Moradinejad MH, et al. (2014) Interleukin-6, interleukin-1 gene cluster and interleukin-1 receptor polymorphisms in Iranian patients with juvenile systemic lupus erythematosus. Eur Cytokine Netw 25:35–40PubMed
11.
go back to reference Maddah M, Harsini S, Rezaei A, et al. (2016) Association of interleukin-2, but not interferon-gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis. Allergol Immunopathol (Madr) Maddah M, Harsini S, Rezaei A, et al. (2016) Association of interleukin-2, but not interferon-gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis. Allergol Immunopathol (Madr)
12.
go back to reference Ziaee V, Rezaei A, Harsini S, et al. (2016) Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis. Clin Rheumatol Ziaee V, Rezaei A, Harsini S, et al. (2016) Polymorphisms of genes encoding interleukin-4 and its receptor in Iranian patients with juvenile idiopathic arthritis. Clin Rheumatol
13.
go back to reference Harsini S, Ziaee V, Tahghighi F, et al. (2016) Association of interleukin-2 and interferon-gamma single nucleotide polymorphisms with juvenile systemic lupus erythematosus. Allergol Immunopathol (Madr) Harsini S, Ziaee V, Tahghighi F, et al. (2016) Association of interleukin-2 and interferon-gamma single nucleotide polymorphisms with juvenile systemic lupus erythematosus. Allergol Immunopathol (Madr)
14.
go back to reference Harsini S, Ziaee V, Maddah M, et al. (2016) Interleukin 10 and transforming growth factor beta 1 gene polymorphisms in juvenile idiopathic arthritis. Bratisl Lek Listy 117:258–262PubMed Harsini S, Ziaee V, Maddah M, et al. (2016) Interleukin 10 and transforming growth factor beta 1 gene polymorphisms in juvenile idiopathic arthritis. Bratisl Lek Listy 117:258–262PubMed
15.
go back to reference Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012) The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 61:665–671CrossRefPubMed Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012) The association between interleukin-6 polymorphisms and rheumatoid arthritis: a meta-analysis. Inflamm Res 61:665–671CrossRefPubMed
16.
go back to reference Smolen JS, Beaulieu A, Rubbert-Roth A, et al. (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371:987–997CrossRefPubMed Smolen JS, Beaulieu A, Rubbert-Roth A, et al. (2008) Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 371:987–997CrossRefPubMed
17.
go back to reference Petty RE, Southwood TR, Manners P, et al. (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed Petty RE, Southwood TR, Manners P, et al. (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMed
18.
go back to reference Amirzargar AA, Naroueynejad M, Khosravi F, et al. (2008) Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 19:104–112PubMed Amirzargar AA, Naroueynejad M, Khosravi F, et al. (2008) Cytokine single nucleotide polymorphisms in Iranian populations. Eur Cytokine Netw 19:104–112PubMed
19.
20.
go back to reference Robak T, Gladalska A, Stepien H, Robak E (1998) Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis. Mediat Inflamm 7:347–353CrossRef Robak T, Gladalska A, Stepien H, Robak E (1998) Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis. Mediat Inflamm 7:347–353CrossRef
22.
go back to reference Ogilvie EM, Fife MS, Thompson SD, et al. (2003) The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 48:3202–3206CrossRefPubMed Ogilvie EM, Fife MS, Thompson SD, et al. (2003) The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 48:3202–3206CrossRefPubMed
23.
go back to reference Li F, Xu J, Zheng J, et al. (2014) Association between interleukin-6 gene polymorphisms and rheumatoid arthritis in Chinese Han population: a case-control study and a meta-analysis. Sci Rep 4:5714PubMedPubMedCentral Li F, Xu J, Zheng J, et al. (2014) Association between interleukin-6 gene polymorphisms and rheumatoid arthritis in Chinese Han population: a case-control study and a meta-analysis. Sci Rep 4:5714PubMedPubMedCentral
24.
go back to reference Arman A, Coker A, Sarioz O, Inanc N, Direskeneli H (2012) Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population. Rheumatol Int 32:2199–2201CrossRefPubMed Arman A, Coker A, Sarioz O, Inanc N, Direskeneli H (2012) Lack of association between IL-6 gene polymorphisms and rheumatoid arthritis in Turkish population. Rheumatol Int 32:2199–2201CrossRefPubMed
25.
go back to reference Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. (2009) Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol 27:964–970PubMed Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, et al. (2009) Interleukin-6 gene -174 promoter polymorphism is associated with endothelial dysfunction but not with disease susceptibility in patients with rheumatoid arthritis. Clin Exp Rheumatol 27:964–970PubMed
26.
go back to reference Ceccarelli F, Perricone C, Fabris M, et al. (2011) Transforming growth factor beta 869C/T and interleukin 6-174G/C polymorphisms relate to the severity and progression of bone-erosive damage detected by ultrasound in rheumatoid arthritis. Arthritis Res Ther 13:R111CrossRefPubMedPubMedCentral Ceccarelli F, Perricone C, Fabris M, et al. (2011) Transforming growth factor beta 869C/T and interleukin 6-174G/C polymorphisms relate to the severity and progression of bone-erosive damage detected by ultrasound in rheumatoid arthritis. Arthritis Res Ther 13:R111CrossRefPubMedPubMedCentral
27.
go back to reference Jancic I, Arsenovic-Ranin N, Sefik-Bukilica M, et al. (2013) 174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. Rheumatol Int 33:1481–1486CrossRefPubMed Jancic I, Arsenovic-Ranin N, Sefik-Bukilica M, et al. (2013) 174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. Rheumatol Int 33:1481–1486CrossRefPubMed
28.
go back to reference Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M (2005) IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol 34:109–113CrossRefPubMed Pawlik A, Wrzesniewska J, Florczak M, Gawronska-Szklarz B, Herczynska M (2005) IL-6 promoter polymorphism in patients with rheumatoid arthritis. Scand J Rheumatol 34:109–113CrossRefPubMed
Metadata
Title
Association of interleukin-6 single nucleotide polymorphisms with juvenile idiopathic arthritis
Authors
Vahid Ziaee
Marzieh Maddah
Mohammad-Hassan Moradinejad
Arezou Rezaei
Samaneh Zoghi
Maryam Sadr
Sara Harsini
Nima Rezaei
Publication date
01-01-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 1/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3407-6

Other articles of this Issue 1/2017

Clinical Rheumatology 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.